Persistent and distressing psychotic-like experiences using adolescent brain cognitive development℠ study data
- PMID: 34782711
- PMCID: PMC9106814
- DOI: 10.1038/s41380-021-01373-x
Persistent and distressing psychotic-like experiences using adolescent brain cognitive development℠ study data
Abstract
Childhood psychotic-like experiences (PLEs) are associated with a range of impairments; a subset of children experiencing PLEs will develop psychiatric disorders, including psychotic disorders. A potential distinguishing factor between benign PLEs versus PLEs that are clinically relevant is whether PLEs are distressing and/or persistent. The current study used three waves of Adolescent Brain Cognitive Development℠ (ABCD) study PLEs assessments to examine the extent to which persistent and/or distressing PLEs were associated with relevant baseline risk factors (e.g., cognition) and functioning/mental health service utilization domains. Four groups varying in PLE persistence and distress endorsement were created based on all available data in ABCD Release 3.0, with group membership not contingent on complete data: persistent distressing PLEs (n = 272), transient distressing PLEs (n = 298), persistent non-distressing PLEs (n = 221), and transient non-distressing PLEs (n = 536) groups. Using hierarchical linear models, results indicated youth with distressing PLEs, whether transient or persistent, showed delayed developmental milestones (β = 0.074, 95%CI:0.013,0.134) and altered structural MRI metrics (β = -0.0525, 95%CI:-0.100,-0.005). Importantly, distress interacted with PLEs persistence for the domains of functioning/mental health service utilization (β = 0.079, 95%CI:0.016,0.141), other reported psychopathology (β = 0.101, 95%CI:0.030,0.170), cognition (β = -0.052, 95%CI:0.-0.099,-0.002), and environmental adversity (β = 0.045, 95%CI:0.003,0.0.86; although no family history effects), with the interaction characterized by greatest impairment in the persistent distressing PLEs group. These results have implications for disentangling the importance of distress and persistence for PLEs with regards to impairments, including functional, pathophysiological, and environmental outcomes. These novel longitudinal data underscore that it is often only in the context of distress that persistent PLEs were related to impairments.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Figures


Similar articles
-
Examining the Most Important Risk Factors for Predicting Youth Persistent and Distressing Psychotic-Like Experiences.Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Sep;9(9):939-947. doi: 10.1016/j.bpsc.2024.05.009. Epub 2024 Jun 5. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 38849031 Free PMC article.
-
Longitudinal Trajectories of Cognition and Neural Metrics as Predictors of Persistent Distressing Psychotic-Like Experiences Across Middle Childhood and Early Adolescence.bioRxiv [Preprint]. 2025 Jan 22:2025.01.20.633817. doi: 10.1101/2025.01.20.633817. bioRxiv. 2025. PMID: 39896525 Free PMC article. Preprint.
-
Distressing psychotic-like experiences, cognitive functioning and early developmental markers in clinically referred young people aged 8-18 years.Soc Psychiatry Psychiatr Epidemiol. 2022 Mar;57(3):461-472. doi: 10.1007/s00127-021-02168-9. Epub 2021 Sep 3. Soc Psychiatry Psychiatr Epidemiol. 2022. PMID: 34480219 Free PMC article.
-
Predictors of persisting psychotic like experiences in children and adolescents: A scoping review.Schizophr Res. 2019 Jul;209:32-39. doi: 10.1016/j.schres.2019.05.012. Epub 2019 May 17. Schizophr Res. 2019. PMID: 31109737
-
Clinical significance of psychotic-like experiences in children and adolescents.Psychiatr Pol. 2017 Apr 30;51(2):271-282. doi: 10.12740/PP/63894. Epub 2017 Apr 30. Psychiatr Pol. 2017. PMID: 28581537 Review. English, Polish.
Cited by
-
Psychotic-like experiences in childhood and early adolescence: Clarifying the construct and future directions.Schizophr Res. 2022 Aug;246:205-206. doi: 10.1016/j.schres.2022.06.030. Epub 2022 Jul 6. Schizophr Res. 2022. PMID: 35809352 Free PMC article. No abstract available.
-
Distress related to psychotic experiences: Enhancing the world health organization composite international diagnostic interview psychosis screen.Int J Methods Psychiatr Res. 2023 May 17;33(1):e1977. doi: 10.1002/mpr.1977. Online ahead of print. Int J Methods Psychiatr Res. 2023. PMID: 37194720 Free PMC article.
-
Mediating effect of risk propensity between impulsivity and psychotic experiences among Lebanese young adults.Discov Ment Health. 2025 Jun 10;5(1):85. doi: 10.1007/s44192-025-00223-4. Discov Ment Health. 2025. PMID: 40493258 Free PMC article.
-
Independent and joint effects of genomic and exposomic loads for schizophrenia on psychotic experiences in adolescents of European ancestry.Schizophrenia (Heidelb). 2025 Feb 22;11(1):26. doi: 10.1038/s41537-025-00569-2. Schizophrenia (Heidelb). 2025. PMID: 39984505 Free PMC article.
-
Independent and joint effects of genomic and exposomic loads for schizophrenia on distressing and persisting psychotic experiences in adolescence.medRxiv [Preprint]. 2024 Nov 11:2024.11.11.24316985. doi: 10.1101/2024.11.11.24316985. medRxiv. 2024. Update in: Schizophrenia (Heidelb). 2025 Feb 22;11(1):26. doi: 10.1038/s41537-025-00569-2. PMID: 39606383 Free PMC article. Updated. Preprint.
References
-
- Laurens KR, Hodgins S, Maughan B, Murray RM, Rutter ML, Taylor EA. Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9–12 years. Schizophr Res 2007; 90(1–3): 130–146. - PubMed
-
- van der Steen Y, Myin-Germeys I, van Nierop M, Ten Have M, de Graaf R, van Dorsselaer S et al. ‘False-positive’ self-reported psychotic experiences in the general population: an investigation of outcome, predictive factors and clinical relevance. Epidemiology and psychiatric sciences 2019; 28(5): 532–543. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- U24 DA041147/DA/NIDA NIH HHS/United States
- U01 DA051039/DA/NIDA NIH HHS/United States
- K23 MH121792/MH/NIMH NIH HHS/United States
- K05 AA017242/AA/NIAAA NIH HHS/United States
- P50 NS022343/NS/NINDS NIH HHS/United States
- U01 DA041093/DA/NIDA NIH HHS/United States
- U24 DA041123/DA/NIDA NIH HHS/United States
- U01 DA051038/DA/NIDA NIH HHS/United States
- U01 DA041156/DA/NIDA NIH HHS/United States
- U01 DA041025/DA/NIDA NIH HHS/United States
- U01 DA041106/DA/NIDA NIH HHS/United States
- U01 DA041117/DA/NIDA NIH HHS/United States
- U01 DA041148/DA/NIDA NIH HHS/United States
- U01 DA041120/DA/NIDA NIH HHS/United States
- T32 MH018261/MH/NIMH NIH HHS/United States
- U01 DA041134/DA/NIDA NIH HHS/United States
- U01 DA041022/DA/NIDA NIH HHS/United States
- U01 DA041089/DA/NIDA NIH HHS/United States
- U01 DA050988/DA/NIDA NIH HHS/United States
- U01 DA041028/DA/NIDA NIH HHS/United States
- U01 DA041048/DA/NIDA NIH HHS/United States
- U01 DA041174/DA/NIDA NIH HHS/United States
- L30 MH120574/MH/NIMH NIH HHS/United States